The Company has informed the Exchange about appointment of Company Secretary and Compliance Officer of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of National Peroxide Ltd met on February 5, 2026 and approved two key items. First, unaudited financial results for Q3 FY26 (Oct-Dec 2025) and nine months ended December 31, 2025, which show the company swung to a loss of about Rs 224.64 lakhs in Q3 FY26 against a profit of Rs 183.23 lakhs in the previous quarter (Q2 FY26). For nine months FY26, the company posted a loss of Rs 151.90 lakhs versus a profit of Rs 424.37 lakhs in the corresponding nine months of FY25, indicating significant pressure on profitability. Second, the Board approved the appointment of Mr. Akshay Satasiya (ACS 47389) as Company Secretary & Compliance Officer and Key Managerial Personnel with effect from March 9, 2026. He brings over 10 years of experience in secretarial and compliance roles and currently serves as Company Secretary at Naperol Investments Limited.
Weak Q3 performance with the company slipping into a loss — partly due to a one-time exceptional charge of Rs 58.15 lakhs linked to the new Social Security Code 2020 — may weigh on the stock in the near term. The CS appointment is a routine governance update and unlikely to move the needle on its own.